scispace - formally typeset
A

Andrew J. Watson

Researcher at University of Exeter

Publications -  531
Citations -  38911

Andrew J. Watson is an academic researcher from University of Exeter. The author has contributed to research in topics: Blastocyst & Embryonic stem cell. The author has an hindex of 88, co-authored 497 publications receiving 34512 citations. Previous affiliations of Andrew J. Watson include Mansfield University of Pennsylvania & Plymouth Marine Laboratory.

Papers
More filters
Journal ArticleDOI

Evaluation of Physical Health in an In-Patient Psychiatric Rehabilitation Setting

TL;DR: In this paper , a detailed cross-sectional study of physical health measures in an in-patient rehabilitation population in Scotland is presented, with the aims to a) benchmark physical health in this population and b) where possible improve physical health.
Journal ArticleDOI

Selecting Normalizers for MicroRNA RT-qPCR Expression Analysis in Murine Preimplantation Embryos and the Associated Conditioned Culture Media

TL;DR: In this paper , the stability of six commonly used miRNA normalization candidates, as well as small nuclear U6, using five different means of evaluation (BestKeeper, NormFinder, geNorm, the comparative Delta Ct method and RefFinder comprehensive analysis) to assess their stability throughout murine preimplantation embryo development from the oocyte to the late blastocyst stages, both in whole embryos and associated conditioned culture media.
Journal ArticleDOI

Is there a relationship between in‐season injury risk and Y balance or vertical jump in elite youth soccer players?

TL;DR: In this article , a study was conducted to determine whether the Y Balance Test (YBT) or vertical jump can identify those players at risk of suffering injury in elite youth soccer players.
Posted ContentDOI

Trial participants are frequently excluded based on their symptoms rather than their condition: A systematic review of Cochrane reviews and their component trials

TL;DR: This article identified strategies used in the design of recent randomised controlled trials (RCTs) and their associated Cochrane reviews where patients with the same gynaecological condition present with different symptoms.